Treace Medical Concepts Inc (TMCI) - Total Liabilities
Based on the latest financial reports, Treace Medical Concepts Inc (TMCI) has total liabilities worth $106.91 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Treace Medical Concepts Inc - Total Liabilities Trend (2019–2025)
This chart illustrates how Treace Medical Concepts Inc's total liabilities have evolved over time, based on quarterly financial data. See Treace Medical Concepts Inc (TMCI) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Treace Medical Concepts Inc Competitors by Total Liabilities
The table below lists competitors of Treace Medical Concepts Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PetroVietnam General Services Corp
VN:PET
|
Vietnam | ₫10.80 Trillion |
|
Thirumalai Chemicals Limited
NSE:TIRUMALCHM
|
India | Rs28.12 Billion |
|
Síminn hf
IC:SIMINN
|
Iceland | Ikr25.09 Billion |
|
Central Omega Resources Tbk PT
JK:DKFT
|
Indonesia | Rp1.84 Trillion |
|
Bitcoin Infrastructure Acquisition Corp Ltd. Class A Ordinary Shares
NASDAQ:BIXI
|
USA | $242.10K |
|
NXG NextGen Infrastructure Income Fund
NYSE:NXG
|
USA | $54.45 Million |
|
Niko Semiconductor Co Ltd
TWO:3317
|
Taiwan | NT$638.21 Million |
|
Flexsteel Industries Inc
NASDAQ:FLXS
|
USA | $104.87 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Treace Medical Concepts Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Treace Medical Concepts Inc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Treace Medical Concepts Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Treace Medical Concepts Inc (2019–2025)
The table below shows the annual total liabilities of Treace Medical Concepts Inc from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $103.25 Million | -0.91% |
| 2024-12-31 | $104.20 Million | -8.57% |
| 2023-12-31 | $113.97 Million | +15.71% |
| 2022-12-31 | $98.50 Million | +106.28% |
| 2021-12-31 | $47.75 Million | +16.37% |
| 2020-12-31 | $41.03 Million | +54.51% |
| 2019-12-31 | $26.55 Million | -- |
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D M… Read more